Rhabdomyosarcoma MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
:*Hyperintense | :*Hyperintense | ||
:*Prominent flow voids may be seen particularly in extremity lesions. | :*Prominent flow voids may be seen particularly in extremity lesions. | ||
*T1 C+ (Gd): | |||
:*Shows considerable enhancement. | |||
===Cardiac MRI=== | ===Cardiac MRI=== | ||
Cardiac MRI can be used in rhabdomyosarcomas of the heart. | Cardiac MRI can be used in rhabdomyosarcomas of the heart. | ||
Revision as of 14:34, 4 September 2015
|
Rhabdomyosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Rhabdomyosarcoma MRI On the Web |
|
American Roentgen Ray Society Images of Rhabdomyosarcoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
MRI
On MRI, signal characteristics of rhabdomyosarcoma include:
- T1:
- Low to intermediate intensity, isointense to adjacent muscle.
- Areas of haemorrhage are common in alveolar and pleomorphic subtypes.
- T2:
- Hyperintense
- Prominent flow voids may be seen particularly in extremity lesions.
- T1 C+ (Gd):
- Shows considerable enhancement.
Cardiac MRI
Cardiac MRI can be used in rhabdomyosarcomas of the heart.
ACC/AHA Guidelines- ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance[1] (DO NOT EDIT)
| “ |
CMR may be used for clinical evaluation of cardiac masses, extracardiac structures, and involvement and characterization of masses in the differentiation of tumors from thrombi. |
” |
References
- ↑ American College of Cardiology Foundation Task Force on Expert Consensus Documents. Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA; et al. (2010). "ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents". Circulation. 121 (22): 2462–508. doi:10.1161/CIR.0b013e3181d44a8f. PMC 3034132. PMID 20479157.